secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001104659-26-012356
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iradimed reports record Q4 revenue $22.7M, EPS $0.50; raises dividend to $0.20
------------------------------------------------------------------------------

- Q4 2025 revenue $22.7M (+17% YoY); GAAP diluted EPS $0.50 (+25%), non-GAAP $0.54 (+23%).
- Full year 2025 revenue $83.8M (+14% YoY); GAAP diluted EPS $1.75 (+17%), non-GAAP $1.93 (+16%).
- Quarterly dividend raised 18% to $0.20/share from $0.17, payable March 6, 2026 to holders of record Feb 23.
- FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP EPS $2.06-2.21.
- Initial 3870 next-gen MRI pump shipped in Q4; full rollout begins Q1 2026 with meaningful H2 revenue contribution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000110465926012356/0001104659-26-012356-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000110465926012356/irmd-20260210x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-012356

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer